Notes From The J.P. Morgan Health Care Conference
Executive Summary
From the Jan. 11-14 J.P. Morgan health care conference in San Francisco, editors of the 1IN VIVO Blog reported on both formal company presentations and the meeting buzz. Their notes are collected below:
You may also be interested in...
With Antiviral Sales Booming, Gilead Expects A Strong Year
While sales for its existing HIV franchise products were very strong, Gilead looks ahead to beginning Phase III of its proprietary "quad" pill.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011